Home > Financial Ratios > CONCORD BIOTECH

CONCORD BIOTECH
Core EBITDA Growth

    Back to All Ratios
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 21.3829.11-12.9944.86-

What is the latest Core EBITDA Growth ratio of CONCORD BIOTECH ?

The latest Core EBITDA Growth ratio of CONCORD BIOTECH is 21.38 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202421.38
Mar202329.11
Mar2022-12.99
Mar202144.86
Mar2020-

How is Core EBITDA Growth of CONCORD BIOTECH Trending?

Years Core EBITDA Growth % Change
Mar2024 21.38
-26.55
Mar2023 29.11
Positive
Mar2022 -12.99
Negative
Mar2021 44.86
0
Mar2020 0 -

Other Financial Ratios of CONCORD BIOTECH


Compare Core EBITDA Growth ratio of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹19,530.9 Cr -1.6% 2.3% 10.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,595.0 Cr 1.5% 0.9% 2% Stock Analytics
DIVIS LABORATORIES ₹174,635.0 Cr -0.5% -1.2% 45.5% Stock Analytics
CIPLA ₹126,894.0 Cr 7.2% 4.5% 2.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,685.0 Cr 3.5% 8.4% 16.7% Stock Analytics
DR REDDYS LABORATORIES ₹107,373.0 Cr 3.7% -1.1% -6.8% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

-1.6%

2.3%

10.8%

SENSEX

-1.6%

-3.4%

0.9%


You may also like the below Video Courses